These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 661071)

  • 21. Examination of the urinary potential of hyperuricosuric patients to retard calcium oxalate precipitation.
    Goldwasser B; Sarig S; Azoury R; Orda S; Boichis H; Wax Y; Many M
    Eur Urol; 1985; 11(1):40-3. PubMed ID: 3987747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine citrate and calcium in calcium nephrolithiasis.
    Parks JH; Coe FL
    Adv Exp Med Biol; 1986; 208():445-9. PubMed ID: 3565157
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG; Peacock M; Nordin BE
    Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
    [No Abstract]   [Full Text] [Related]  

  • 24. Uric acid/calcium oxalate nephrolithiasis. Clinical and biochemical findings in 86 patients.
    Rapado A; Castrillo JM; Diaz-Curiel M; Traba ML; Santos M; Cifuentes-Delatte L
    Adv Exp Med Biol; 1980; 122A():109-13. PubMed ID: 7424622
    [No Abstract]   [Full Text] [Related]  

  • 25. Uric acid nephrolithiasis.
    Gutman AB; Yü TF
    Am J Med; 1968 Nov; 45(5):756-79. PubMed ID: 4879835
    [No Abstract]   [Full Text] [Related]  

  • 26. [Whewellite and weddellite: toward a different etiopathogenesis. The significance of morphological typing of calculi].
    Daudon M; Réveillaud RJ
    Nephrologie; 1984; 5(5):195-201. PubMed ID: 6531056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allopurinol treatment of uric-acid disorders in calcium-stone formers.
    Coe FL; Raisen L
    Lancet; 1973 Jan; 1(7795):129-31. PubMed ID: 4118468
    [No Abstract]   [Full Text] [Related]  

  • 28. The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers.
    Coe FL; Moran E; Kavalich AG
    J Chronic Dis; 1976 Dec; 29(12):793-800. PubMed ID: 1010873
    [No Abstract]   [Full Text] [Related]  

  • 29. Medical treatment of idiopathic calcium nephrolithiasis.
    Surian M; Malberti F; Colussi G; De Ferrari ME; Rombolà G; Benazzi E; Minetti L
    Contrib Nephrol; 1987; 58():172-5. PubMed ID: 3691120
    [No Abstract]   [Full Text] [Related]  

  • 30. [Oxalate stones and hyperuricuria].
    Hartung R; Bergmann M
    Helv Chir Acta; 1974; 41(3):405-10. PubMed ID: 4849335
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic basis of renal-stone disease.
    Broadus AE; Thier SO
    N Engl J Med; 1979 Apr; 300(15):839-45. PubMed ID: 34098
    [No Abstract]   [Full Text] [Related]  

  • 33. [The influence of dietary factors on renal lithiasis].
    Jaeger P
    Ther Umsch; 1986 Oct; 43(10):779-84. PubMed ID: 3824255
    [No Abstract]   [Full Text] [Related]  

  • 34. [Urate nephrolithiasis. Cause of consequence?].
    Mertz DP
    Fortschr Med; 1976 Jul; 94(20-21):1160-4. PubMed ID: 955552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of low calcium diet on urinary calcium and oxalate excretion in patients with idiopathic calcium nephrolithiasis.
    Colussi G; Antonacci A; Surian M; Pontoriero G; Rombolà G; De Ferrari ME; Cosci P; Malberti F; Minetti L
    Contrib Nephrol; 1984; 37():22-6. PubMed ID: 6713874
    [No Abstract]   [Full Text] [Related]  

  • 36. Uric acid saturation in calcium nephrolithiasis.
    Coe FL; Strauss AL; Tembe V; Le Dun S
    Kidney Int; 1980 May; 17(5):662-8. PubMed ID: 7401461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers.
    Robertson WG; Peacock M
    Clin Sci; 1972 Oct; 43(4):499-506. PubMed ID: 4653589
    [No Abstract]   [Full Text] [Related]  

  • 38. Determinants of supersaturation levels and crystallization rates of calcium oxalate from urines of normal humans and stone formers: effects of nondialyzable materials.
    Gill WB; Roma MJ
    J Surg Res; 1976 Jul; 21(1):45-9. PubMed ID: 933515
    [No Abstract]   [Full Text] [Related]  

  • 39. [Oxalic lithiasis and disorder of uric acid metabolism].
    Mugler A
    J Urol Nephrol (Paris); 1970 Dec; 76(12):423-34. PubMed ID: 5522994
    [No Abstract]   [Full Text] [Related]  

  • 40. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.